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EXPERIMENTAL NICKEL CONTACT SENSITIZATION IN MAN*
JAMES J. VANDENBERG, M.D. AND WILLIAM L. EPSTEIN, M.D.
Nickel dermatitis constitutes a difficult clinical
problem. Its etiology and pathogenesis remain
uncertain. Current concepts view the disease as
an example of contact-type delayed hypersensi-
tivity, but an immunologic basis has not been
firmly established. In fact, Rostenberg et at (1)
have argued persuasively against this idea; they
suggest an inborn enzymatic defect to explain the
disease.
In the main, previous experimental work has
not taken into account the irritating qualities of
nickel solutions. Many studies are negated by the
fact that frankly irritating evocative patch testing
preparations were used. In addition, no one has
pre-tested their subjects to detect and eliminate
previously sensitized persons.
MATERIALS
The subjects were 178 healthy male volunteerst.
The sensitizing agent was 25 per cent nickel
chloride (NiCI2) dissolved in water with 0.1 per
cent sodium lauryl sulfate (SLS) to aid penetra-
tion. The eliciting solutions were 1, 2, 5, and 10
per cent NiCl2 and nickel sulfate (NiSO4) in water.
Experiment I—Irritation
A survey of the literature was confusing as to
the proper concentration of nickel salts for patch
testing. To assess previous work we first studied
the irritant properties of NiC12. Nickel chloride
in concentrations of 1, 2, 5, and 10 per cent aqueous
solutions was dropped onto 1.5 cm gauze squares
and the saturated patches were applied to the
backs of 39 subjects. The test sites were completely
occluded for 24, 48, and 96 hours and examined
10 to 15 minutes and 5 days after removal of the
patches.
The results (Fig. 1) indicate that irritation is
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directly proportional to concentration and dura-
tion of application. Clearly, 10 per cent NiCl2
with occlusion causes too much irritation to have
value as a predictive patch test. Fisher and
Shapiro (2) drew similar conclusions from their
studies. The 5 per cent occluded patch test also
showed significant irritation; it cannot be used
effectively either.
On the other hand, non-occluded patches
covered only with a band-aid (Fig. 2) in the same
subjects showed almost no reactions after 48
hours:
Irritant Patch Test Reactions
Without Occlusion
1% 2% 5% 10%
48 hours 0/39 0/39 0/39 3/39(8%)
These data suggest that such a test with 5 per
cent NiCI2 solution ordinarily will not be a pri-
mary irritant. However, we found that 0.1 per
cent SLS added to the 5 per cent NiCI2 solution
resulted in increased irritation:
Positive Reactions with Occlusion
With 0.1 per cent SLS Without 0.1 per cent SLS
20/38 = 53 per cent 11/38 = 29 per cent
We adopted the 5 per cent NiCl2 patch covered
only with a band-aid (non-occluded) as the stand-
ard for our sensitizing experiments.
Experiment II—Sensitization
We next undertook a deliberate attempt to
sensitize previously non-reactive normal human
volunteers. All subjects were pre-tested at least
once with non-occluded patches of 5 per cent NiCl2
solution. Six positive reactors were detected and
removed from the study. Clinical experience in
the United States led us to believe that nickel is a
weak sensitizer, so we utilized the "triple freeze"
technic for sensitization (3). This method utilizes
several factors which enhance sensitization, i.e.
irritation, occlusion, and repeated exposure on
the same limb to bombard the same regional nodes
with a maximum amount of allergen. Briefly, a 3
em circle of skin on the upper arm was frozen for
3 seconds with dichlorodifluoromethane (Freon-
12). A Lintine dise* saturated with 25 per cent
NiCl2 and 0.1 per cent SLS solution was applied
* Johnson and Johnson.
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FIG. 1. Per cent of irritancy reactions related to concentration and duration of exposure. Clearly 5
per cent NiC12 with occlusion causes too much irritation to be used as a standard for patch testing.
had been truly sensitized. These subjects were
then compared by serial patch testing with the 6
sensitive subjects who had been removed from
the study. No significant differences in depth or
degree of reactivity were observed.
Clinically the latent period in nickel sensitivity
appears to be quite long with prolonged and re-
peated metal contact required before the onset
of the dermatitis. We wondered if a second "triple
freeze" would result in a greater frequency of sen-
sitization. Twenty negative reactors previously
exposed to nickel by the "triple freeze" technic
were re-exposed 4 months later by the same
method. One subject was found to have developed
sensitivity in the interim. The results of the sec-
ond "triple freeze" were:
Percent Sensitized
5/19 = 26%
Clearly, prolonged exposure raises the frequency
of sensitization to weak allergens such as nickel.
FIG. 2. Examples of the occluded (0) and non-
occluded (N) patches used in these studies.
immediately to the frozen area and then occluded
firmly with plastic tape for 2 days. This procedure
was performed three times at 5 day intervals.
Standard eliciting patch tests were applied to the
opposite forearm 10 days after the third freeze
and observed at 2, 3, and 5 days.
The results showed:
Per cent Sensitized
10/172 = 9%
A number of other subjects gave questionable
reactions, but repeated tests with 1, 2, and 5 per
cent NiC12 indicated that only these 16 subjects
Experiment 111—Cross Sensitivity
The status of cross-sensitivity between other
metals and nickel is not settled. We assessed re-
activity to 2 per cent and 1 per cent cobalt
chloride (CoC12), 1 per cent and 0.5 per cent cop-
per sulfate (CuSo4), and 0.5 per cent and 0.1 per
cent potassium dichromatc (K2Cr1O7) in eight
subjects who had developed nickel sensitivity.
The test sites were examined at 2 and 5 days. One
subject showed a primary irritant response to
each concentration of CuSO4, but no other re-
actions occurred.
Clinical Status of Subjects
It should be emphasized that none of our sub-
jects, either those previously sensitized or those
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experimentally sensitized, demonstrated nickel
dermatitis to his watch, watchband, or identifica-
tion tags. The subjects apparently have remained
subclinieally sensitive during 6 months of obser-
vation.
DISCUSSION
From these data we conclude that sensitization
to nickel can be accomplished under carefully
controlled conditions. The controversial findings
reported in the literature probably reflect lack of
adequate controls. Despite enthusiastic reports of
sensitization in guinea pigs (4—6), these have not
been confirmed (7, 8) and most workers, including
us, believe the reactions seen were irritant rather
than allergic in nature (9).
Haxthausen (10) and Burkhardt (11) each re-
ported no difficulty in sensitizing a few subjects to
25 per cent NiSO4. These results have not been
generally accepted for a number of reasons. They
used 10 per cent NiSO4 for evocation and as we
and others (9, 12) have shown this causes primary
irritation. Also, they failed to test their subjects
for prior sensitivity, and repeated tests were not
used to rule out spurious responses. However, it is
clear from their data that certain subjects were
truly sensitive to nickel; their experimental de-
sign, unfortunately, does not reveal how this was
accomplished.
It is not surprising, therefore, that a thoughtful
analysis of the problem led Rostenberg et cii (1)
to conclude that nickel sensitivity is not an al-
lergic response. They believe it represents an
"enzymatic interference in a biochemical]y devi-
ant person." The argument rests on analogy and
negative correlations. We present positive data
supporting the concept of delayed hypersensitiv-
ity as the cause of nickel dermatitis. We have
ruled out the possibility of primary irritation as a
factor; and repeated pre-testing eliminated previ-
ously sensitive persons. Furthermore, the fre-
quency of reactivity was increased by repeated
sensitizing exposures; this would not be expected
in a biochemically deviant population. Finally,
patch tests with weak dilutions of nickel salts
months after sensitization still gave positive
results. Hence, only positive transfer experiments
remain to be done to make certain that nickel
dermatitis is a variety of delayed hyper-
sensitivity.
One unexplained aspect of nickel dermatitis
is its high incidence noted in Europe (13—15) and
the relatively low frequency in the United States
(2). Our findings suggest that a substantial
number of Americans have the ability to develop
nickel sensitivity. Indeed, six subjects removed
from the study had a previously acquired
sensitivity. Yet no one showed a clinical erup-
tion.
Marcussen (16) believes subclinical reactors
form a small percentage of the total. Calnan
states that patch test reactivity often is not
correlated with clinical disease (17). We also
suggest the percentage is much higher. The
situation in poison ivy-oak sensitivity offers a
pertinent analogy. Here, about 50 per cent of the
population is clinically sensitive, but another
35-40 per cent are subelinically sensitive and may
become reactive at any time (18). Perhaps
Rostenberg et cii (1) are correct; some factor
other than hypersensitivity is required to
precipitate the curious pattern of clinical disease
(12). Whether genetics or some other factor play
this role remains to be determined.
The final point of discussion concerns cross-
sensitivity to other metals such as cobalt,
copper, and chromium. Stephan Epstein and
others (19-23) believe significant cross-sensi-
tivity exists, but the view is not generally held
(14). Marcussen (14) points out that correction
for occupational double exposure gives no sup-
port to the concept of cross-sensitivity. In our
studies experimental sensitization to nickel
engendered no reactivity to other metals. We
agree with Marcussen and others that cases of
dual metal hypersensitivity undoubtedly arise
from multiple primary sensitizations.
5UMMAEY
1. Nickel chloride solutions are very irritating
when applied to human skin with occlusion. A
5 per cent solution causes no irritation when
applied without occlusion under a band-aid for
48 hours. This preparation can be used for
evocative patch testing. However, we emphasize
that a 5 per cent solution with occlusion is
irritating.
2. Contact-type delayed hypersensitivity can
be induced experimentally in man. No cross-
sensitivity to other metals was demonstrated
under these conditions.
3. Discussion includes consideration of the
intriguing fact that no experimentally sensiti-
tized subject demonstrated clinical sensitivity to
416 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
the metal in his ordinary environment, such as
watch, watchband, or identification tags.
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DISCUSSION
DR. RICHARD L. D0B5ON (Chapel Hill, N. C.):
This is an important contribution to a common
clinical problem.
The incidence of sensitization was reported to
be 9%. Since nickel dermatitis is a problem in
the atopie individual almost exclusively and
since the incidence of atopy in the general
population is thought to be about 10%, I wonder
if the authors were able to correlate an atopie
history with the ability to sensitize?
Secondly, the problem was raised about the
sensitized individuals not being clinically
reactive. I assume that all their subjects were
males. Since women have nickel dermatitis more
commonly than men, the lack of clinical disease
in their subjects may not reflect a lack of sufficient
sensitivity but rather reflects perhaps, the degree
of exposure to the metal in clothing, for example.
DR. ADOLPH RO5TENBERG, Jn. (Chicago,
Illinois): Doctors Vandenberg and Epstein have
apparently produced an alteration in cutaneous
reactivity to nickel. The question is, what is the
proper label for this alteration? This is not just a
point in semantics, in that labels betoken
mechanism. They interpreted the alteration as
the development of an allergic sensitization, and
this may be correct; but I think that the matter
has not been unequivocally settled.
Elsewhere* my colleagues and I have
questioned the propriety of the label "allergic
sensitization" for eczematous reactions to certain
metals, in that these do not conform to the
classic delayed types of sensitivity developed by
simple chemicals, such as picryl chloride, 2:4
dinitrochlorobenzene, etc. The eczematous
reactions produced by certain metals differ in
that (1) it is not possible to correlate structure
* Rostenberg, A.; Perkins, A. J.; and Fox,J. M.: Eczematous Reactions to Nickel, Cobalt,
and Chromium in Dermatoses due to Environ-
mental and Physical Factors. Ed. by Rees B.
Rees. Thomas. Springfield, 1962, P. 250.
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and reactivity; (2) the reactions arc often non-
specific, i.e., a person will react to more than one
metal; (3) it is not possible to transfer the
reactivity; (4) the reactive and the normal person
fail to show a difference with respect to the
absorption of the metal; and (5) it has not been
possible to "desensitize". In general, classical
delayed eczematous sensitizations to simple
chemicals exhibit all of points (1) to (5). The
absence of any one of these points is not crucial,
but the sum total argues strongly against the
allergic interpretation for the pathogcncsis of the
metal cczcmas.
Da. M. B. SIJLzBEEGER (Washington, D. C.):
I would like to comment not only on this paper
but also on Dr. Rostcnberg's discussion of the
paper, if I may.
First of all, I would like to say that I have
never quite understood Dr. Rostcnbcrg's explana-
tion of immunologic phenomena with incubation
periods, accelerated responses, etc., as simply
belonging to genetically deviant individuals. Of
course, the people who get sensitized more easily
are deviant in a certain way from the ones who do
not get sensitized easily. Immunologic reactions
also usually depend upon genetically determined
degrees of susceptibility to immunologic altera-
tions so there is no quarrel with the idea that
certain forms of genetic deviation arc actually
the basis of an immunologic acquired alteration.
The other point I would like to comment on is
that it has not been my clinical impression that
the contact type of allergic cczematous dermatitis
due to nickel is substantially more common in
the atopic individuals than it is in the nonatopic
group. It is true that one gets positive patch-
test reactions with 5 per cent solutions of nickel
sulfate in atopic dermatitis, i.e., in individuals
with an atopic skin, much more commonly than
one does if one tests normals, so-called normal
skins. I believe Steiner was the first one to
demonstrate this, and after that, studies were
done at our school by Joseph Goodman and then
by Charles Miller, Arthur Hyman, and others.
All these studies showed the reaction to be not an
allergic response to nickel but a primary-irritant
response. It is apparent that the threshold of the
atopic skin for responses of primary irritation to
quite a series of substances, including nickel
salts, arsenicals, iodides, feather and house dust
allergens, and others, which do not produce
reactions in so-called normal skins, is lower in the
atopic skin. The clinical appearance and the
histologic appearance of these reactions to nickel
are quite different from the real contact type of
allergic eczcmatous responses which are on an
immunologic basis. These primary irritant
responses generally originate around the mouths
of the follicles and arc much more prone to
predominantly polymorphonuclear lcukocytic
infiltrations and to clinically papulo-pustular
lesions than arc the allergic contact reactions.
One of the prime difficulties in coming to a
decision as to the proper label for a reaction is
that there are no absolute criteria for asserting
that the reaction is on an allergic basis. In
allergic reactions of the immediate type serologic
evidence may furnish proof. In the delayed type
the best evidence is the cellular transfer, which,
in man, has not been imiformly accomplishable.
What other interpretation can be given to the
altered reactivity seen? It will be recalled that,
in order to produce the alteration, the authors
first had to develop a fair degree of irritation at
the experimental site. It has been shown that the
development of a primary irritation has an effect
on the skin at other sites. This is not only to be a
matter of clinical observation but has been
experimentally verified. Doctors Haebcrlin and
Fox (Primary Irritation of the Skin. A.M.A.
Archives of Dermatology 80: 690-699, December,
1959), in our laboratory, have shown this in the
guinea pig. In order to check on this hypothesis,
it would be worthwhile for the authors to deter-
mine whether the subjects who displayed the
altered reactivity to nickel also displayed an
altered reactivity to borderline primary irritant
concentrations of other materials. A final test as
to the nature of the reaction developed would
be to see if it could be experimentally transferred
to normal recipients with cells from the subjects
in whom the altered reactivity was developed.
As to the question raised concerning the
distinction between a reaction brought about by a
genetically induced biochemical deviation and an
allergic sensitization, I believe these arc quite
separate phenomena and that it is important to
keep them separate. In a genetically induced bio-
chemical deviation, one has an individual in
whom there is a deficiency of an enzyme system
brought about because of some difference in the
genetic makeup of that person. This deficiency
can be of any degree. The consequences of this
deficiency may only be manifest when an appro-
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priate stress stimulus is met, e.g., persons who
have a deficiency of glucose-6-phosphate dehy-
drogenase behave perfectly normally until they
meet a drug such as primaquin. So far as is known,
there is no way to transfer this genetic deficiency
to other persons, nor is there any way to induce
it in a person who does not possess it. On the
other hand, genetic factors play a role in the
development of an allergic sensitization, in that
if a person is not of the appropriate genetic stock
they probably cannot become sensitized to a
given substance; but with many "strong sensi-
tizers", e.g., poison ivy, 2:4 dinitroehloro.
benzene, foreign sera, apparently genetic factors
play a minimal role, in that almost any person
can become sensitized. Once a person has become
sensitized, there is either serological or cellular
evidence for that sensitization, and it is passively
transferable to normal persons, either by means
of serum or by means of living cells. Furthermore,
once a sensitization has developed, the mechanism
is the same for a given type of sensitization,
regardless of the substance to which the person
is sensitized; whereas, in a genetically induced
biochemical deviation the mechanism in each
instance is contingent on the specific enzyme
involved.
Da. JAMES J. VANOENBERG (in closing): I wish
to thank the diseussers for their cogent remarks.
In answer to Dr. Dobson, our volunteers were
prisoners; they have almost no history of atopy.
I agree with Dr. Sulzberger that the response in
atopics probably represents primary irritaney.
I cannot comment about responses in women.
We studied only men.
Dr. Rostenberg's comments were very much
appreciated. As I said, we induced nickel hyper-
sensitivity but did not produce clinical disease.
These men still tolerate their watch bands and
identification bracelets. We wonder if the
development of clinical disease may depend
upon some biochemical deviant. In fact, this may
be the difference between the person who becomes
sensitized and the one who becomes sensitized
and then develops clinical dermatitis. The status
of subclinical reactors has not been thoroughly
explored in the case of nickel sensitivity.
In regard to the possibility of false-positive
reactions because of extreme inflammation of the
skin elsewhere, I should point out that the
hypersensitivity persisted long after clinical
healing occurred. Patch tests 6 months later still
gave strongly positive reactions. We have induced
an altered tissue reactivity that presumably is
immunologic in nature. Passive transfer experi-
ments are under way at the present time, and I
hope to report on them later.
